Trial Profile
A Double Blind Placebo Control Trial of Mirabegron for Medical Expulsive Therapy and to Manage Stent Pain for Ureteral Stones(Protocol # 01-16-20-02)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2022
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Pain; Ureteral calculi
- Focus Therapeutic Use
- 31 Jan 2020 Status changed from recruiting to completed.
- 17 Jul 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2019.
- 17 Jul 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.